UCB - Ordinary Share Capital



UCB reported EUR584M in Ordinary Share Capital for its fiscal semester ending in December of 2024.


Ordinary Share Capital Change Date
Alcon AG USD 20M 0 Mar/2025
Almirall EUR 214.79M 189.17M Jun/2025
Amarin USD 308.15M 2.85M Mar/2025
argenx SE 61.17M 405.3K Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Genmab DKK 10M 56M Mar/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Orion EUR 140.69M 48.49M Jun/2025
Recordati EUR 205.56M 179.42M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
UCB EUR 584M 0 Dec/2024
Unibail Rodamco EUR 713.1M 16.3M Dec/2024